In: Anatomy and Physiology
There are 5 parts to the question.
Patient Medical History
Georgia is a 32 year old woman who has been suffering from recurrent (sometimes severe) headaches, and periods of fatigue since late childhood (~10-11 years of age). In her early twenties (21 years of age) she was diagnosed with gastroesophageal reflux disease (GERD) and began to experience periods of unexplained abdominal pain.
Georgia’s symptoms have waxed and waned over times, sometimes she feels fine but other times (since ~10-11 years of age) the headaches, fatigue and abdominal pain (since ~21 years of age) seem overwhelming. Lately the fatigue and abdominal pains have been particularly bad.
Georgia is afraid to eat because she does not know when the abdominal pain will strike or what is causing it. She has begun to lose weight but her food restriction has not addressed the pain. Regardless of whether she has eaten a large or small meal, and regardless of ingredients the pain can occur.
Georgia’s doctor performed several tests and noticed symptoms of inflammation in some areas of the intestine, after ruling out other conditions her doctor has suggested Georgia may have Inflammatory Bowel Disease (IBD). However, IBD would not explain why Georgia sometimes experiences upper abdominal pain or why the location of the pain seems to move around different areas of the abdomen.
Georgia feels tired all of the time; the amount of sleep she gets does not seem to lessen the fatigue. She finds mornings especially difficult but fatigue is present throughout the day. She finds it difficult to concentrate and her performance at work has begun to suffer. She sometimes feels too tired to climb the stairs to her second floor apartment.Her doctor sent her to a sleep clinic but an overnight sleep observation study did not find anything abnormal.
While Georgia is most concerned with the abdominal pain and fatigue she has other symptoms as well.
Georgia's Symptoms
Georgia’s doctor has consulted some colleagues who recommended a full blood work up and tests to measure the levels of some key immune response molecules.
Georgia's Test Results
After reviewing her tests Georgia’s doctor concludes she has Mast Cell Activation Syndrome (MCAS), a disease characterized by chronic multi-system inflammation. Her doctor rules out mastocytocis (accumulation of mast cells).
Basically Georgia’s mast cell responses are too strong which could be because she has too many mast cells, her mast cells are hyperactive or both. Since her doctor has ruled out mastocytosis there are not an abnormal number of mast cells.
We initially looked at white blood cells commonly found in circulation and therefore when it came to granulocytes focused on basophils, eosinophils and neutrophils. Mast cells are also granulocytes but are found in tissues.
We initially looked at white blood cells commonly found in circulation and therefore when it came to granulocytes focused on basophils, eosinophils and neutrophils. Mast cells are also granulocytes but are found in tissues.
In other words, how does it “make sense” – if you tell an immunologist that a chronic multi-system inflammatory disorder is caused by overactive mast cells that explanation “makes sense”, why? (Don’t forget there are three words – chronic, multi-system, inflammation)
Dermatographism
Let’s revisit the dermatographism now that you know more about Georgia’s condition.
Dermatographism is sometimes referred to as “skin writing disease”. In people with dermatographia/dermatographism non-pathogenic stimuli like mild scratching can cause localized hives to quickly and transiently (temporarily) form at the site of the stimulation.
The immune responses that cause the “writing” are not triggered by pathogens but by simple pressure/scratching (sometimes heat or other non-pathogenic stimuli too). However, the underlying reactions are similar to the immune responses you’d see if a foreign particle was introduced under the skin.
This is also true for conditions like MCAS. For example Georgia’s mast cells are over-reacting to a scratch on her skin but they are still releasing all the same signalling molecules and causing a similar reaction to ‘normal’ mast cell responses (i.e., they might be reacting more strongly, and responding to things that aren’t dangerous but they aren’t acting radically different).
One of Georgia's symptoms was dermatographism.
Some symptoms of MCAS occur after an easily identifiable trigger/triggering event and some seem to appear randomly. Whether triggers can be identified (and therefore modified/avoided) depends on the symptom and/or patient. Even those symptoms that appear “random” can still be due to a triggering event but triggers can be variable and not always easy to identify.
For example, Georgia only notices the symptoms of dermatographism when pressure is applied to her skin (like a scratch or wearing clothing that is too tight). She has begun to wear looser clothing and is less likely to scratch at minor skin irritations. However her stomach pains seem to be random and nothing she eats or doesn’t eat impacts the presence or level of pain.
Depending on the type and severity of symptoms, and how they impact a patient’s quality of life there are different treatment options. Usually trying to identify and avoid triggers of mast cell responses, when possible, is the first step. Why might avoidance of triggers be the first step instead of trying to modify the mast cell responses (i.e., “fix” the mast cells; stop them from overacting)? (Hint: this is a general question, no particular pathways necessary; tie your answer into what you know of the immune responses in general)
Like many patients, Georgia could identify triggers for some of her symptoms and not others. Georgia’s doctor prescribed an H1 and H2 antihistamine, as well as cromoglicic acid to help lower the overactivity of her mast cells. Georgia was also given a proton-pump inhibitor to help with the stomach pain and GERD, and told to take acetaminophen for more general pain. She was put on a brief course of prednisone to decrease gastrointestinal inflammation but is now off the prednisone.
Georgia is feeling better and while her symptoms are not gone she now has less acute episodes.
A. Immune responses can contribute to the abdominal pain in human. inflammatory bowel syndrome(IBS) can be developed is case of acute infectious gastroenteritis. inflammatory bowel syndrome(IBS) can also be seen in case of microscopic colitis or celiac disease. So, IBS symptoms can be seen after some immune response of our body. So, immune response contribute abdominal pain.
B. Mild to transient rise in serum tryptase of Georgia's Test results signifies that tryptase can upregulate the functions of protease-activated receptor 2, that will increases the secretion of neuropeptides in body and cause immune response and finally can lead to the symptoms of IBS and abdominal pain.
Mild rise in Histamine level in her body shows that mast cell degranulation occur in the body. This increased histamine, tryptase level causes neuronal hyperexcitability. This mast cell degranulation can be cause of IBS.
Increased urinary histamine metabolites and urinary PGD2 level of her body is quite obvious. Her body is facing inflammatory response in the abdomen and due to mast cell degranulation histamine metabolites are increased in body. PGD2 biosynthesis is increased in the inflamed tissue. This PGD2 play as a marker of some immune or inflammation. Due to inflammation and for pro inflammatory response PGD2 synthesis is also increased and their level is also increased in the urine.